Lexicon Pharmaceuticals (LXRX) Non Operating Income (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Non Operating Income of $1.5 million for Q1 2026, down 30.46% year-over-year from $2.2 million in Q1 2025, and up 20.45% on a QoQ basis from $1.3 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 17 years of Non Operating Income data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Non Operating Income fell 30.46% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 29.79% YoY) and the FY2025 annual result came in at $6.9 million, down 43.8% from the prior year.
- Non Operating Income advanced to $1.5 million in Q1 2026 per LXRX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Non Operating Income topped out at $4.6 million in Q3 2024 and bottomed at $14000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $1.6 million (2025), against an average of $1.7 million.
- The widest annual swing landed in 2023, when Non Operating Income surged 7250.0%; it then plunged 76.19% in 2024.
- Tracing LXRX's Non Operating Income over 5 years: stood at $887000.0 in 2022, then soared by 170.8% to $2.4 million in 2023, then sank by 76.19% to $572000.0 in 2024, then soared by 123.95% to $1.3 million in 2025, then rose by 20.45% to $1.5 million in 2026.
- Per Business Quant, the three latest LXRX Non Operating Income figures stand at $1.5 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 572,000.00 |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 887,000.00 |
| Sep 30, 2022 | 572,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 875,000.00 |
| Sep 30, 2020 | 301,000.00 |
| Jun 30, 2020 | 633,000.00 |
| Mar 31, 2020 | 958,000.00 |
| Dec 31, 2019 | 1.27 Mn |
| Sep 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 691,000.00 |
| Mar 31, 2019 | 789,000.00 |
| Dec 31, 2018 | 810,000.00 |
| Sep 30, 2018 | 783,000.00 |
| Jun 30, 2018 | 910,000.00 |
| Mar 31, 2018 | 1.01 Mn |
| Dec 31, 2017 | 561,000.00 |
| Sep 30, 2017 | 415,000.00 |
| Jun 30, 2017 | 448,000.00 |
| Mar 31, 2017 | 530,000.00 |
| Dec 31, 2016 | 545,000.00 |
| Sep 30, 2016 | 564,000.00 |
| Jun 30, 2016 | 547,000.00 |
| Mar 31, 2016 | 637,000.00 |
| Dec 31, 2015 | 68,000.00 |
| Sep 30, 2015 | 82,000.00 |
| Jun 30, 2015 | 269,000.00 |
| Mar 31, 2015 | 153,000.00 |
| Dec 31, 2014 | 1.34 Mn |
| Sep 30, 2014 | 287,000.00 |
| Jun 30, 2014 | 538,000.00 |
| Mar 31, 2014 | 94,000.00 |
| Dec 31, 2013 | 175,000.00 |
| Sep 30, 2013 | 11,000.00 |
| Jun 30, 2013 | -4,000.00 |
| Mar 31, 2013 | 34,000.00 |
| Dec 31, 2012 | 297,000.00 |
| Sep 30, 2012 | 4,000.00 |
| Jun 30, 2012 | 21,000.00 |
| Mar 31, 2012 | -4,000.00 |
| Dec 31, 2011 | 8,000.00 |
| Sep 30, 2011 | 88,000.00 |
| Jun 30, 2011 | 30,000.00 |
| Mar 31, 2011 | 27,000.00 |
| Dec 31, 2010 | 1,000.00 |
| Sep 30, 2010 | -2.70 Mn |
| Jun 30, 2010 | -643,000.00 |